Metabolomic and Lipidomic Biomarkers for Premalignant Liver Disease Diagnosis and Therapy

In recent years, there has been a plethora of attempts to discover biomarkers that are more reliable than α-fetoprotein for the early prediction and prognosis of hepatocellular carcinoma (HCC). Efforts have involved such fields as genomics, transcriptomics, epigenetics, microRNA, exosomes,...

Full description

Bibliographic Details
Main Authors: Diren Beyoğlu, Jeffrey R. Idle
Format: Article
Language:English
Published: MDPI AG 2020-01-01
Series:Metabolites
Subjects:
Online Access:https://www.mdpi.com/2218-1989/10/2/50

Similar Items